AGM Statement

DawMed Systems PLC
27 April 2007


27 APRIL 2007

                               DAWMED SYSTEMS PLC
                          ('Dawmed' or 'the Company')

                                 AGM STATEMENT


At today's Annual General Meeting of DawMed, the medical devices company which
designs, manufactures, sells, distributes and services healthcare
decontamination equipment used by Secondary Care NHS Trust hospitals, private
hospitals and Primary Care practitioners and clinics, the Executive Chairman,
Kevin Gilmore, commented:


KEY POINTS:


   • Enhanced Product Portfolio gaining ground;
   • Good progress in areas referred to in 2006 Final Results Statement;
   • Export Department established;
   • Export Manager appointed;
   • New Wassenburg 'pass through' WD machines now being delivered;
   • Wassenburg 'Dry 300' cabinets selling well;
   • Litigation trial date allocated by Court;
   • Expansion of Support Services Department Engineers


'Since it is only a month ago that your Company's Annual Report and Accounts
were distributed to all shareholders, there is not a great deal that I can add
to my Statement in that document.


That said, as regards the litigation against the trade debtor whom your Company
claims breached its contract with the Company, a date for trial has been
allocated by the Court towards the end of June 2007 and the Board remains
confident of a satisfactory outcome of those proceedings.


So far as the UK is concerned, there can be no doubt that, in common with almost
all NHS supply chain companies, particularly SMEs, your Company has continued to
experience unprecedented levels of NHS cut backs on purchases of both capital
equipment and revenue supplies. However, the new NHS financial year began on 1
April 2007 and it is to be expected that a more normal level of NHS business
will soon be resumed.


The Directors are pleased that the current wide range of products and services
has generated growing interest in the UK, but more particularly in the potential
for export. In this regard an Export Department was established and an export
manager appointed on 1 April 2007. Your Board anticipates that, in accordance
with your Company's declared strategy, this area of activity will not only
benefit the Group directly through increased sales, but also indirectly by
lessening the degree of dependence upon the NHS.


Good progress is being made in all the other areas referred to in my 2006 Final
Results Statement and I hope to be able to inform the market of such progress in
more detail in the not too far distant future.'


All resolutions proposed at the Annual General Meeting were duly passed.


                                    --ENDS--

Enquiries:

DawMed Systems plc                                         Tel: [phone]
Kevin Gilmore, Executive Chairman

Beaumont Cornish Limited                                   Tel: [phone]
Roland Cornish

Bishopsgate Communications Limited                         Tel:  [phone]
Dominic Barretto
Jenni Herbert


For further information please visit DawMed's website at www.dawmed.com


                      This information is provided by RNS
            The company news service from the London Stock Exchange